Yoji Kyotani
About
In The Last Decade
Yoji Kyotani
22 papers receiving 331 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 145
- Physiology 86
- Cardiology and Cardiovascular Medicine 49
- Pulmonary and Respiratory Medicine 45
- Epidemiology 41
Countries citing papers authored by Yoji Kyotani
This map shows the geographic impact of Yoji Kyotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoji Kyotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoji Kyotani more than expected).
Fields of papers citing papers by Yoji Kyotani
This network shows the impact of papers produced by Yoji Kyotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoji Kyotani. The network helps show where Yoji Kyotani may publish in the future.
Co-authorship network of co-authors of Yoji Kyotani
This figure shows the co-authorship network connecting the top 25 collaborators of Yoji Kyotani. A scholar is included among the top collaborators of Yoji Kyotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoji Kyotani. Yoji Kyotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 4 | |
| 7 | 16 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 9 | |
| 11 | 37 | |
| 12 | 79 | |
| 13 | 25 | |
| 14 | 12 | |
| 15 | 2 | |
| 16 | 21 | |
| 17 | 6 | |
| 18 | 8 | |
| 19 | 13 | |
| 20 | Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.